Replies to post #3075 on Biotech Values

[rkrw]

<<Today’s deal with MRK and DOVP’s prior out-license of the insomnia med, Indiplon, to NBIX give DOVP some credibility as a discovery/early development engine>>

Everything dovp has was inlicensed!!